Home » CELLARTIS AB RAISES EUR 8 MILLION FOR THE DEVELOPMENT OF HUMAN FUNCTIONAL CELLS
CELLARTIS AB RAISES EUR 8 MILLION FOR THE DEVELOPMENT OF HUMAN FUNCTIONAL CELLS
Cellartis AB is pleased to announce the successful completion of a financing round led by a new investor, Bio Fund Management Ltd of Finland (BioFund). Existing shareholders, InnovationsKapital, Catella Healthcare Investments, T-bolaget, Texcel and Barnwik AB, also participated in the financing round.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1125201XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May